Literature DB >> 22484256

Thermoluminescence and EPR studies of nanocrystalline Nd₂O₃:Ni²⁺ phosphor.

B Umesh1, B Eraiah, H Nagabhushana, S C Sharma, D V Sunitha, B M Nagabhushana, C Shivakumara, J L Rao, R P S Chakradhar.   

Abstract

Nanocrystalline Nd(2)O(3):Ni(2+) (2 mol%) phosphor has been prepared by a low temperature (∼400°C) solution combustion method, in a very short time (<5 min). Powder X-ray diffraction results confirm the single hexagonal phase of nanopowders. Scanning electron micrographs show that nanophosphor has porous nature and the particles are agglomerated. Transmission electron microscopy confirms the nanosize (20-25 nm) of the crystallites. The electron paramagnetic resonance (EPR) spectrum exhibits a symmetric absorption at g≈2.77 which suggests that the site symmetry around Ni(2+) ions is predominantly octahedral. The number of spins participating in resonance (N) and the paramagnetic susceptibility (χ) has been evaluated. Raman study show major peaks, which are assigned to F(g) and combination of A(g)+E(g) modes. Thermoluminescence (TL) studies reveal well resolved glow peaks at 169°C along with shoulder peak at around 236°C. The activation energy (E in eV), order of kinetics (b) and frequency factor (s) were estimated using glow peak shape method. It is observed that the glow peak intensity at 169°C increases linearly with γ-dose which suggest that Nd(2)O(3):Ni(2+) is suitable for radiation dosimetry applications.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484256     DOI: 10.1016/j.saa.2012.02.082

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  Design, characterization and catalytic evaluation of halometallic ionic liquid incorporated Nd2O3 nanoparticles ([smim][FeCl4]-@Nd2O3) for the synthesis of N-aryl indeno pyrrole derivatives.

Authors:  Mohd Umar Khan; Ryhan Abdullah Rather; Zeba N Siddiqui
Journal:  RSC Adv       Date:  2020-12-21       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.